{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T22:57:43Z","timestamp":1760482663109,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Advance provision of misoprostol to women during antenatal care aims to achieve broader access to uterotonics for the prevention of postpartum hemorrhage. Studies of this community-based approach usually involve antenatal education as well as timely postpartum follow-up visits to confirm maternal and neonatal outcomes. The MamaMiso study in Mbale, Uganda sought to assess the feasibility of conducting follow-up visits in the postpartum period following advance provision of misoprostol for postpartum hemorrhage prevention. MamaMiso recruited women during antenatal care visits. Participants were asked to contact the research team within 48\u00a0h of giving birth so that postpartum follow-up visits could be carried out at their homes. Women\u2019s baseline and delivery characteristics were collected and analyzed with respect to follow-up time (\u2018on time\u2019\u00a0\u2264\u00a07\u00a0days, \u2018late\u2019\u00a0&gt;\u00a07\u00a0days, and \u2018lost to follow up\u2019). Every woman who was followed up late due to a failure to report the delivery was asked for the underlying reasons for the delay. When attempts at following up participants were unsuccessful, a file note was generated explaining the details of the failure. We abstracted data and identified themes from these notes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 748 recruited women, 700 (94%) were successfully followed up during the study period, 465 (62%) within the first week postpartum. The median time to follow up was 4\u00a0days and was similar for women who delivered at home or in facilities and for women who had attended or unattended births. Women recruited at the urban hospital site (as opposed to rural health clinics) were more likely to be lost to follow up or followed up late. Of the women followed up late, 202 provided a reason. File notes explaining failed attempts at follow up were generated for 164 participants. Several themes emerged from qualitative analysis of these notes including phone difficulties, inaccurate baseline information, misperceptions, postpartum travel, and the condition of the mother and neonate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Keeping women connected to the health system in the postpartum period is feasible, though reaching them within the first week of their delivery is challenging. Understanding characteristics of women who are harder to reach can help tailor follow-up efforts and elucidate possible biases in postpartum study data.<\/jats:p>\n                <jats:p><jats:italic>Trial Registration Number<\/jats:italic> ISRCTN70408620 December 28, 2011<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-017-2849-5","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T12:39:57Z","timestamp":1509021597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostol"],"prefix":"10.1186","volume":"10","clinical-trial-number":[{"clinical-trial-number":"isrctn70408620","registry":"10.18810\/isrctn"}],"author":[{"given":"James","family":"Ditai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Durocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan E.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Ononge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"key":"2849_CR1","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/S0140-6736(06)69522-6","volume":"368","author":"RJ Derman","year":"2006","unstructured":"Derman RJ, Kodkany BS, Goudar SS, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet. 2006;368:1248\u201353.","journal-title":"Lancet"},{"key":"2849_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1471-0528.2010.02807.x","volume":"118","author":"N Mobeen","year":"2011","unstructured":"Mobeen N, Durocher J, Zuberi NF, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG Int J Obstet Gynaecol. 2011;118:353\u201361.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"2849_CR3","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/j.1471-0528.2005.00711.x","volume":"112","author":"G Walraven","year":"2005","unstructured":"Walraven G, Blum J, Dampha Y, et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG Int J Obstet Gynaecol. 2005;112:1277\u201383.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"2849_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/bmj.331.7519.723","volume":"331","author":"L Hoj","year":"2005","unstructured":"Hoj L. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ. 2005;331:723.","journal-title":"BMJ"},{"key":"2849_CR5","unstructured":"Wannmacher L. Safety Profile of Misoprostol for Obstetrical Indications. Commissioned report for the 18th WHO Expert Committee on the Selection and use of Essential Medicines (March 2011). http:\/\/www.who.int\/selection_medicines\/committees\/expert\/18\/applications\/Misoprostol_safety_review.pdf."},{"key":"2849_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2393-13-44","volume":"13","author":"J Smith","year":"2013","unstructured":"Smith J. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date. BMC Pregnancy Childbirth. 2013;13:44.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2849_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijgo.2009.12.003","volume":"108","author":"H Sanghvi","year":"2010","unstructured":"Sanghvi H, Ansari N, Prata NJV, Gibson H, Ehsan AT, Smith JM. Prevention of postpartum hemorrhage at home birth in Afghanistan. Int J Gynecol Obstet. 2010;108:276\u201381.","journal-title":"Int J Gynecol Obstet"},{"key":"2849_CR8","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1016\/S0020-7292(06)60016-7","volume":"94","author":"S Rajbhandari","year":"2006","unstructured":"Rajbhandari S, Pun A, Hodgins S, Rajendra P. Prevention of postpartum haemorrhage at homebirth with use of misoprostol in Banke District, Nepal. Int J Gynecol Obstet. 2006;94:S143\u20134.","journal-title":"Int J Gynecol Obstet"},{"key":"2849_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/1471-0528.12447","volume":"121","author":"S Geller","year":"2014","unstructured":"Geller S, Carnahan L, Akosah E, et al. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana. BJOG. 2014;121:319\u201325.","journal-title":"BJOG"},{"key":"2849_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1471-2393-14-189","volume":"14","author":"JM Smith","year":"2014","unstructured":"Smith JM, Baawo SD, Subah M, et al. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia. BMC Pregnancy Childbirth. 2014;14:189.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2849_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijgo.2014.05.016","volume":"127","author":"JM Smith","year":"2014","unstructured":"Smith JM, Dimiti A, Dwivedi V, et al. Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan. Int J Gynaecol Obstet. 2014;127:183\u20138.","journal-title":"Int J Gynaecol Obstet"},{"key":"2849_CR12","first-page":"166","volume":"18","author":"C Ejembi","year":"2014","unstructured":"Ejembi C, Shittu O, Moran M, et al. Community-level distribution of misoprostol to prevent postpartum hemorrhage at home births in northern Nigeria. Afr J Reprod Health. 2014;18:166\u201375.","journal-title":"Afr J Reprod Health"},{"key":"2849_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12884-015-0650-9","volume":"15","author":"AD Weeks","year":"2015","unstructured":"Weeks AD, Ditai J, Ononge S, et al. The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial. BMC Pregnancy Childbirth. 2015;15:219.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2849_CR14","doi-asserted-by":"publisher","first-page":"e17155","DOI":"10.1371\/journal.pone.0017155","volume":"6","author":"D Montagu","year":"2011","unstructured":"Montagu D, Yamey G, Visconti A, Harding A, Yoong J. Where do poor women in developing countries give birth? A multi-country analysis of demographic and health survey data. PLoS ONE. 2011;6:e17155.","journal-title":"PLoS ONE"},{"key":"2849_CR15","unstructured":"Home visits for the newborn child: a strategy to improve survival. Joint Statement WHO & UNICEF; 2009. http:\/\/apps.who.int\/iris\/bitstream\/10665\/70002\/1\/WHO_FCH_CAH_09.02_eng.pdf?ua=1&ua=1."},{"key":"2849_CR16","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/S0140-6736(08)60835-1","volume":"371","author":"AH Baqui","year":"2008","unstructured":"Baqui AH, El-Arifeen S, Darmstadt GL, et al. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial. Lancet. 2008;371:1936\u201344.","journal-title":"Lancet"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2849-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-017-2849-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2849-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:47:33Z","timestamp":1628614053000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-2849-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2849"],"URL":"https:\/\/doi.org\/10.1186\/s13104-017-2849-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2017,10,26]]},"assertion":[{"value":"23 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"516"}}